抗苗勒管激素与整倍体胚胎移植结局的关系
该回顾性队列研究纳入2014至2018年某学术医疗中心389个采用24染色体PGT-A的IVF周期,分析AMH与母亲年龄同单整倍体冻融胚胎移植结局的关系。多因素分析显示AMH与阳性bHCG或持续妊娠无显著关联,AMH<1 ng/ml组整倍体流产率显著低于参考组,母亲年龄与移植结局无显著关联。
要点
- AMH<1与≥5 ng/ml组阳性bHCG和持续妊娠率与参考组无显著差异。
- AMH<1 ng/ml组整倍体流产率显著低于AMH 1至<5 ng/ml参考组。
- 取卵时年龄和移植时年龄均与整倍体胚胎移植结局无显著关联。
核心结论
- 校正潜在混杂因素后,AMH浓度与整倍体胚胎移植后的阳性bHCG或持续妊娠无关。
- 母亲年龄与整倍体胚胎移植结局无关。
- 作者认为需要在更大队列中进一步研究。
研究设计与样本
- 2014年至2018年在某学术医疗中心开展的回顾性队列研究。
- 纳入389个采用24染色体第5/6天胚胎植入前非整倍体遗传学检测(PGT-A)的IVF周期。
- 采用多因素逻辑回归分析AMH和年龄与IVF结局的关系,控制患者和周期混杂因素,纳入至少有一个整倍体胚胎可移植的患者。
主要发现
- 未校正的总体阳性bHCG率为69.2%,每次移植持续妊娠率为52.7%,阳性bHCG周期的流产率为23.4%。
- 与AMH 1至<5 ng/ml参考组相比,AMH<1组阳性bHCG的OR为0.65(0.30-1.44),AMH 5+组为1.27(0.61-2.65)。
- 与参考组相比,AMH<1组持续妊娠的OR为0.80(0.43-1.50),AMH 5+组为1.41(0.68-2.90)。
- 与参考组相比,AMH<1组整倍体流产率显著更低,OR为0.32(0.12-0.85,P=0.022);AMH 5+组流产率无统计学差异。
- 取卵时年龄和移植时年龄均与移植结局无显著关联。
局限性
- 作者结论指出需要在更大队列中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: To investigate the association between anti-Müllerian hormone (AMH) concentration and maternal age with single euploid cryopreserved embryo transfer. DESIGN: Retrospective cohort study from 2014 to 2018 at an academic medical centre, including 389 cycles of IVF with 24-chromosome Day 5/6 preimplantation genetic testing for aneuploidies (PGT-A). Multivariate logistic regression was used to study AMH and age in relation to IVF outcomes (positive beta human chorionic gonadotrophin [bHCG], ongoing pregnancy and pregnancy loss rates) for patients with at least one euploid embryo for transfer, controlling for patient and cycle confounders. RESULTS: In this cohort the overall unadjusted positive bHCG rate was 69.2% and ongoing pregnancy rate was 52.7% per transfer, while the pregnancy loss rate was 23.4% per cycle with positive bHCG. Multivariate analysis found that compared with the reference group of AMH 1 to <5 ng/ml, AMH <1 and 5+ did not have any significant difference in positive bHCG (odds ratio, OR 0.65 [0.30-1.44] and 1.27 [0.61-2.65] for AMH <1 and AMH 5+, respectively) or ongoing pregnancy (OR 0.80 [0.43-1.50] and 1.41 [0.68-2.90]). However, AMH <1 had statistically significant lower euploid miscarriage rates compared with the reference group with OR 0.32 (0.12-0.85, P = 0.022); AMH 5+ did not have any statistical difference in miscarriage rate. Neither age at retrieval nor age at transfer were significantly associated with transfer outcomes. CONCLUSIONS: AMH concentration was not associated with positive bHCG or ongoing pregnancy for euploid embryo transfers after adjustment for potential confounders. Maternal age was not associated with euploid transfer outcomes. Further study is warranted in larger cohorts.
引用
- Wang A, Lathi R, Kort J, et al. Anti-Müllerian hormone in association with euploid embryo transfer outcomes. Reprod Biomed Online. 2019. PMID: 31395517. doi:10.1016/j.rbmo.2019.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。